BioXcel Therapeutics Files 8-K
Ticker: BTAI · Form: 8-K · Filed: Aug 1, 2025 · CIK: 1720893
Sentiment: neutral
Topics: 8-k, corporate-event
Related Tickers: BXCL
TL;DR
BXcel filed an 8-K, something happened.
AI Summary
BioXcel Therapeutics, Inc. filed an 8-K on August 1, 2025, reporting an 'Other Event'. The filing does not contain specific details about the event, dollar amounts, or names, but it indicates a corporate action or significant update has occurred.
Why It Matters
This filing signals a material event or change for BioXcel Therapeutics, Inc., requiring disclosure to investors and the public.
Risk Assessment
Risk Level: medium — The lack of specific details in the filing creates uncertainty, which can be a risk for investors.
Key Players & Entities
- BioXcel Therapeutics, Inc. (company) — Registrant
- August 1, 2025 (date) — Date of earliest event reported
FAQ
What specific event is being reported in this 8-K filing?
The filing is categorized under 'Other Events' but does not provide specific details about the nature of the event.
When was this 8-K filing submitted?
The filing was submitted on August 1, 2025.
What is the principal executive office address for BioXcel Therapeutics, Inc.?
The address is 555 Long Wharf Drive, New Haven, CT 06511.
What is the telephone number for BioXcel Therapeutics, Inc.?
The telephone number is (475) 238-6837.
What is the Standard Industrial Classification code for BioXcel Therapeutics, Inc.?
The SIC code is 2834, Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 1, 2025 regarding BioXcel Therapeutics, Inc. (BTAI).